Licence version

Release date

Explanation of changes from previous version

• External links updated.

3

• Field added for digital object identifier (DOI) version number.
• Revised authorship criteria for consistency with ICMJE criteria.
• Authors are directed to the Cochrane Editorial and Publishing Policy Resource for Cochrane’s updating policy.
• Removed text about Cochrane Review Group approval ahead of publication (moved to Cochrane Editorial and Publishing Policy Resource).
• Changed following author rights:
  • Revised the rights to post in repositories and Scholarly Collaboration Networks (SCNs).
  • Added sharing rights with colleagues.
• Updated the section on contributions owned by Employer to include US National Institutes of Health (US NIH) employees and grantees, and UK National Institute for Health Research (UK NIHR).
• Updated hyperlinks and minor text edit updates, including the addition of generic email addresses for all Wiley contacts and directing authors to Rightslink for permission requests.

Note: Note that version 3 of the Cochrane standard (green OA) licence for publication form was due to launch on 21September 2016. Due to a technical hitch the new licence for publication form was not actually available until 14 October 2016. During this time 53 Cochrane Reviews and 29 Cochrane protocols were published under the previous version of the licence for publication. We would like to apologize for this and assure all Authors affected that we will honour the new licence terms, as described above. If you have any questions about this, please contact the Cochrane Editorial & Methods Department (emd@cochrane.org).

2

Open access changes:

• Amended to reflect the introduction of green open access.
• Introduces the new right for authors to post the final accepted version of the Protocolor Review (in a format specified by the Publisher) in an institutional repository or any repository mandated by the author’s funder, such as [insert an appropriate example], 12 months after publication.
• Introduces text to explain automatic deposition to PMC and free access on CDSR 12 months after publication
• Clarifies the right to post the Protocol or Review as an electronic file on the author’s own website and/or the author’s institution’s intranet (previously stated website), using the PDF version of the article available in the Cochrane Database of Systematic Reviews.

Other change:

• Minor editing to the introductory text in italic as shown in the Policy Manual and RevMan versions (not needed in the Archie version).

1

—

— (Contact the Cochrane Editorial & Methods Department (emd@cochrane.org) for information about earlier versions.)

Licence version*

Release date

Explanation of changes from previous version

• External links updated.

3

• Field added for digital object identifier (DOI) version number.
• Revised authorship criteria for consistency with ICMJE criteria.
• Authors are directed to the Cochrane Editorial and Publishing Policy Resource for Cochrane’s updating policy.
• Removed text about Cochrane Review Group approval ahead of publication (moved to Cochrane Editorial and Publishing Policy Resource).
• Changed following author rights:
  • Revised the rights to post in repositories and Scholarly Collaboration Networks (SCNs).
  • Added sharing rights with colleagues.
• Updated the section on contributions owned by Employer to include US National Institutes of Health (US NIH) employees and grantees, and UK National Institute for Health Research (UK NIHR)
• Updated hyperlinks and minor text edits, including the addition of generic email addresses for all Wiley contacts and directing authors to Rightslink for permission requests.

Note: Note that version 3 of the Cochrane standard (green OA) licence for publication form was due to launch on 21 September 2016. Due to a technical hitch the new licence for publication form was not actually available until 14 October 2016.  During this time 53 Cochrane Reviews and 29 Cochrane protocols were published under the previous version of the licence for publication. We would like to apologise for this and assure all Authors affected that we will honour the new licence terms, as described above. If you have any questions about this, please contact the Cochrane Editorial & Methods Department (emd@cochrane.org).

2

Open access changes:

• Amended to reflect the introduction of green open access.
• Introduces the new right for authors to post the final accepted version of the Protocol or Review (in a format specified by the Publisher) in an institutional repository or any repository mandated by the author’s funder, such as [insert an appropriate example], 12 months after publication.
• Introduces text to explain automatic deposition to PMC and free access on CDSR 12 months after publication
• It also clarifies the right to post the Protocol or Review as an electronic file on the author’s own website and/or the author’s institution’s intranet (previously stated website), using the PDF version of the article available in the Cochrane Database of Systematic Reviews. These new terms are backdated to 1 February 2013 for all authors who have signed the Licence for Publication Form between 1 February 2013 and today.

Other changes:

• New sections added to the Archie and RevMan versions (were already included in the Cochrane Policy Manual version): UK Government work (Crown Copyright); US Government work; Other Government work; World Health Organization (WHO) work.
• New addition: National Institutes of Health (NIH) grantees.
• Minor editing to the introductory text in italic as shown in the Policy Manual and RevMan versions (not needed in the Archie version).

Addendum to licence for publication of a World Health Organization (WHO) manuscript as a Cochrane Review 

• Corrected the number of the addendum clauses.
• Updated the following sentence in Clause 7 to include non-WHO author rights: “The preferred format is “The World Health Organization and [Author X] and [Author Y] retain copyright and all other rights in their respective contributions to the manuscript of this Review as submitted for publication”.”
• Addendum has been prepared as a Microsoft Word (97-2003) file for authors to download from the Cochrane Policy Manual.

1

—

— (Contact the Cochrane Editorial & Methods Department (emd@cochrane.org) for information about earlier versions.)

Licence version

Release date

Explanation of changes from previous version

• External links updated.

2

• Based on Creative Commons v4.0 for CC BY, CC BY-NC, and CC BY NC-ND.
• Field added for digital object identifier (DOI) version number.
• Revised authorship criteria for consistency with ICMJE criteria.
• Authors are directed to the Cochrane Editorial and Publishing Policy Resource for Cochrane’s updating policy, consistent with the standard licence.
• Removed text about Cochrane Review Group approval ahead of publication (moved to Cochrane Editorial and Publishing Policy Resource), consistent with the standard licence.
• Terms of use: removed line around “commercial purposes” in the CC BY licence.
• “permission to republish” sections updated so that they are relevant to individual CC BY licences (e.g. NC/ND versions).
• Changed following author rights:
  • Revised the rights to post in repositories and Scholarly Collaboration Networks (SCNs).
  • Added sharing rights with colleagues.
• Updated the section on contributions owned by Employer to include US National Institutes of Health (US NIH) employees and grantees, and UK National Institute for Health Research (UK NIHR).
• Updated hyperlinks and minor text edit updates, including the addition of generic email addresses for all Wiley contacts and directing authors to Rightslink for permission requests.

1

First version; based on Creative Commons v3.0 for CC BY, CC BY-NC, and CC BY-NC-ND.